Indeed, it has been reported that, in MASH patients, an increase of 1.5 times the BAFF levels is associated with the presence of hepatocyte ballooning and advanced fibrosis [56]. The gene discussed is TNFSF13B; the disease is metabolic dysfunction-associated steatohepatitis.